ConCallIQ
Go Pro
DIVISLAB Diversified 10 Aug 2023

Divi's Laboratories — Q1 FY24

Divis Laboratories reported a consolidated total income of INR 1,859 crore for Q1 FY24, down from INR 2,343 crore in the same quarter last year, reflecting the absence of COVID-...

neutral medium
Compare with...
Revenue ₹1,778 Cr
EBITDA
PAT ₹356 Cr
EBITDA Margin 28%
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Sustained pricing pressure in US/European generics

Management acknowledged potential impact of price pressures in US and European markets on operating margins, though they remain optimistic.

medium · management_commentary
R

Raw material price volatility

While raw material prices are currently softening, management noted that price variations could recur, especially for solvents like acetonitrile.

medium · analyst_question
R

Dependence on custom synthesis project ramp-up

Custom synthesis growth depends on customer approvals and project timelines, which are uncertain and not quarter-to-quarter predictable.

medium · management_commentary